Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Jun 30, 2017

Filed with the SEC on Aug 14, 2017 and accepted by EDGAR at Aug 14, 2017, 20:53 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2017-04-01 to 2017-06-30$0us-gaap:SalesRevenueNet
Revenue6 months2017-01-01 to 2017-06-30$0us-gaap:SalesRevenueNet
Operating income3 months2017-04-01 to 2017-06-30−$23.6kus-gaap:OperatingIncomeLoss
Operating income6 months2017-01-01 to 2017-06-30−$32.4kus-gaap:OperatingIncomeLoss
Income tax3 months2017-04-01 to 2017-06-30$0us-gaap:IncomeTaxExpenseBenefit
Income tax6 months2017-01-01 to 2017-06-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-04-01 to 2017-06-30−$23.6kus-gaap:NetIncomeLoss
Net income6 months2017-01-01 to 2017-06-30−$14.8kus-gaap:NetIncomeLoss
Diluted EPS3 months2017-04-01 to 2017-06-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2017-01-01 to 2017-06-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Total assetsAt period end2017-06-30$0us-gaap:Assets
Current liabilitiesAt period end2017-06-30$128.5kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-06-30$128.5kus-gaap:Liabilities
Shareholders' equityAt period end2017-06-30−$128.5kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-17-043228. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.